Low-Fat Diet + Fish Oil for Prostate Cancer
Trial Summary
What is the purpose of this trial?
This randomized phase II trial will evaluate if a low omega-6, high omega-3 fat diet combined with fish oil has the potential to delay disease progression in patients with prostate cancer undergoing active surveillance.
Research Team
William Aronson
Principal Investigator
Jonsson Comprehensive Cancer Center
Eligibility Criteria
This trial is for men with prostate cancer who are on active surveillance, have a Gleason grade of 3+4 or less, and a PSA level under 20. They must not consume certain supplements or fish oil capsules during the study and be able to visit UCLA for check-ups. Men who've had prior prostate cancer treatments or take specific medications can't join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Behavioral Dietary Intervention (Behavioral)
- Omega-3 Fatty Acid (Omega-3 Fatty Acid)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jonsson Comprehensive Cancer Center
Lead Sponsor
Dr. Aparna Bhaduri
Jonsson Comprehensive Cancer Center
Chief Medical Officer since 2024
MD
Dr. Michael A. Teitell
Jonsson Comprehensive Cancer Center
Chief Executive Officer since 2024
MD, PhD
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School
Pharmavite LLC
Industry Sponsor
Seafood Industry Research Fund
Collaborator